Edible mushrooms: Improving human health and promoting quality life

International Journal of Microbiology

Volumn 2015, Issue , 2015, Pages

  Valverde, María Elena ^a   Hernández Pérez, Talía ^a   Paredes López, Octavio ^a  

^a DEPARTAMENTO DE INGENIERÍA GENÉTICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BASIDIOMYCOTA;

EID: 84922370085     PISSN: 1687918X     EISSN: 16879198     Source Type: Journal    
DOI: 10.1155/2015/376387     Document Type: Review

References (139)

1. S.-T. Chang and P. G. Miles, Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact, CRC Press, Boca Raton, Fla, USA, 2nd edition, 2008.
2. P. G. Ergnl, I. Akata, F. Kalyoncu, and B. Ergnl, "Fatty acid compositions of six wild edible mushroom species, " The Scientific World Journal, vol. 2013, Article ID 163964, 4 pages, 2013.
3. E. Guillamn, A. Garci-Lafuente, M. Lozano et al., "Edible mushrooms: role in the prevention of cardiovascular diseases, " Fitoterapia, vol. 81, no. 7, pp. 715-723, 2010.
4. F. M. N. A. Aida, M. Shuhaimi, M. Yazid, and A. G. Maaruf, "Mushroomas a potential source of prebiotics: a review, " Trends in Food Science and Technology, vol. 20, no. 11-12, pp. 567-575, 2009.
5. S. Patel and A. Goyal, "Recent developments in mushrooms as anticancer therapeutics: a review, " 3 Biotech, vol. 2, no. 1, pp. 1-15, 2012.
6. M. Alves, I. F. R. Ferreira, J. Dias, V. Teixeira, A. Martins, and M. Pintado, "A review on antimicrobial activity of mushroom (Basidiomycetes) extracts and isolated compounds, " Planta Medica, vol. 78, no. 16, pp. 1707-1718, 2012.
7. S. A. Heleno, L. Barros, M. J. Sousa, A. Martins, and I. C. F. R. Ferreira, "Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity, " Food Chemistry, vol. 119, no. 4, pp. 1443-1450, 2010.
8. P. Mattila, K. Knk, M. Eurola et al., "Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms, " Journal of Agricultural and Food Chemistry, vol. 49, no. 5, pp. 2343-2348, 2001.
9. L. Barros, P. Baptista, D. M. Correia, S. Casal, B. Oliveira, and I. C. F. R. Ferreira, "Fatty acid and sugar compositions, and nutritional value of five wild ediblemushrooms fromNortheast Portugal, " Food Chemistry, vol. 105, no. 1, pp. 140-145, 2007.
10. L. Barros, D. M. Correia, I. C. F. R. Ferreira, P. Baptista, and C. Santos-Buelga, "Optimization of the determination of tocopherols in Agaricus sp. edible mushrooms by a normal phase liquid chromatographic method, " Food Chemistry, vol. 110, no. 4, pp. 1046-1050, 2008.
11. I. C. F. R. Ferreira, L. Barros, and R. M. V. Abreu, "Antioxidants in wild mushrooms, " Current Medicinal Chemistry, vol. 16, no. 12, pp. 1543-1560, 2009.
12. E. Pereira, L. Barros, A. Martins, and I. C. F. R. Ferreira, "Towards chemical and nutritional inventory of Portuguese wild edible mushrooms in different habitats, " Food Chemistry, vol. 130, no. 2, pp. 394-403, 2012.
13. J. A. Vaz, S. A. Heleno, A. Martins, G. M. Almeida, M. H. Vasconcelos, and I. C. F. R. Ferreira, "Wild mushrooms Clitocybe alexandri and Lepista inversa: in vitro antioxidant activity and growth inhibition of human tumour cell lines, " Food and Chemical Toxicology, vol. 48, no. 10, pp. 2881-2884, 2010.
14. I. C. F. R. Ferreira, J. A. Vaz, M. H. Vasconcelos, and A. Martins, "Compounds from wild mushrooms with antitumor potential, " Anti-Cancer Agents in Medicinal Chemistry, vol. 10, no. 5, pp. 424-436, 2010.
15. B.-Z. Zaidman, M. Yassin, J. Mahajna, and S. P. Wasser, "Medicinal mushroom modulators of molecular targets as cancer therapeutics, " Applied Microbiology and Biotechnology, vol. 67, no. 4, pp. 453-468, 2005.
16. S. T. Chang and S. P. Wasser, "The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health, " International Journal of Medicinal Mushrooms, vol. 14, no. 2, pp. 95-134, 2012.
17. T. C. Finimundy, G. Gambato, R. Fontana et al., "Aqueous extracts of Lentinula edodes and Pleurotus sajor-caju exhibit high antioxidant capability and promising in vitro antitumor activity, " Nutrition Research, vol. 33, no. 1, pp. 76-84, 2013.
18. S. Yu, V. Weaver, K. Martin, and M. T. Cantorna, "The effects of wholemushrooms during inflammation, " BMC Immunology, vol. 10, article 12, 2009.
19. L. Zhang, C. Fan, S. Liu, Z. Zang, and L. Jiao, "Chemical composition and antitumor activity of polysaccharide from Inonotus obliquus, " Journal of Medicinal Plants Research, vol. 5, no. 7, pp. 1251-1260, 2011.
20. J. Chen and R. Seviour, "Medicinal importance of fungal β-(1→3), (1→6)-glucans, " Mycological Research, vol. 111, no. 6, pp. 635-652, 2007.
21. A. C. Brown and C. I. Waslien, "Stress and nutrition, " in Encyclopedia of Food Sciences and Nutrition, L. Trugo and P. M. Finglas, Eds., Academic Press, London, UK, 2003.
22. A. A. J. Carneiro, I. C. F. R. Ferreira, M. Dueñas et al., "Chemical composition and antioxidant activity of dried powder formulations of Agaricus blazei and Lentinus edodes, " Food Chemistry, vol. 138, no. 4, pp. 2168-2173, 2013.
23. H. G. Kim, D. H. Yoon, W. H. Lee et al., "Phellinus linteus inhibits inflammatory mediators by suppressing redox-based NF-κB and MAPKs activation in lipopolysaccharide-induced RAW 264. 7 macrophage, " Journal of Ethnopharmacology, vol. 114, no. 3, pp. 307-315, 2007.
24. C. Sarikurkcu, B. Tepe, and M. Yamac, "Evaluation of the antioxidant activity of four edible mushrooms from the Central Anatolia, Eskisehir-Turkey: Lactarius deterrimus, Suillus collitinus, Boletus edulis, Xerocomus chrysenteron, " Bioresource Technology, vol. 99, no. 14, pp. 6651-6655, 2008.
25. A. Synytsya, K. Míčková, I. Jablonský et al., "Glucans from fruit bodies of cultivated mushrooms Pleurotus ostreatus and Pleurotus eryngii: structure and potential prebiotic activity, " Carbohydrate Polymers, vol. 76, no. 4, pp. 548-556, 2009.
26. Z. Wang, D. Luo, and Z. Liang, "Structure of polysaccharides from the fruiting body of Hericium erinaceus Pers, " Carbohydrate Polymers, vol. 57, no. 3, pp. 241-247, 2004.
27. P. B. Flegg and G. Maw, "Mushrooms and their possible contribution to the world, " Mushroom Journal, vol. 48, pp. 395-403, 1997.
28. F. H. Gruen and M. W. Wong, "Distribution of cellular amino acids, proteins and total nitrogen during fruit body development in Flammuling velutipes, " Canadian Journal of Botany, vol. 160, pp. 1339-1341, 1982.
29. P. Kalač, "A review of chemical composition and nutritional value of wild-growing and cultivated mushrooms, " Journal of the Science of Food and Agriculture, vol. 93, no. 2, pp. 209-218, 2013.
30. F. S. Reis, L. Barros, A. Martins, and I. C. F. R. Ferreira, "Chemical composition and nutritional value of themostwidely appreciated cultivated mushrooms: an inter-species comparative study, " Food and Chemical Toxicology, vol. 50, no. 2, pp. 191-197, 2012.
31. P. Mattila, P. Salo-Väänänen, K. Könkö, H. Aro, and T. Jalava, "Basic composition and amino acid contents ofmushrooms cultivated in Finland, " Journal of Agricultural and Food Chemistry, vol. 50, no. 22, pp. 6419-6422, 2002.
32. S. J. M. Mdachi, M. H. H. Nkunya, V. A. Nyigo, and I. T. Urasa, "Amino acid composition of some Tanzanian wildmushrooms, " Food Chemistry, vol. 86, no. 2, pp. 179-182, 2004.
33. P. K. Ouzouni, D. Petridis, W.-D. Koller, and K. A. Riganakos, "Nutritional value andmetal content of wild ediblemushrooms collected from West Macedonia and Epirus, Greece, " Food Chemistry, vol. 115, no. 4, pp. 1575-1580, 2009.
34. B. Ribeiro, P. G. de Pinho, P. B. Andrade, P. Baptista, and P. Valentão, "Fatty acid composition of wild edible mushrooms species: a comparative study, " Microchemical Journal, vol. 93, no. 1, pp. 29-35, 2009.
35. J. Erjavec, J. Kos, M. Ravnikar, T. Dreo, and J. Sabotič, "Proteins of higher fungi-from forest to application, " Trends in Biotechnology, vol. 30, no. 5, pp. 259-273, 2012.
36. X.-M. Wang, J. Zhang, L.-H. Wu et al., "A mini-review of chemical composition and nutritional value of edible wildgrown mushroom from China, " Food Chemistry, vol. 151, pp. 279-285, 2014.
37. S. P. Wasser, "Current findings, future trends, and unsolved problems in studies of medicinal mushrooms, " Applied Microbiology and Biotechnology, vol. 89, no. 5, pp. 1323-1332, 2011.
38. S. A. Heleno, L. Barros, A. Martins, M. J. R. P. Queiroz, C. Santos-Buelga, and I. C. F. R. Ferreira, "Portugal: chemical compoundswith antioxidant properties, " Journal of Agricultural and Food Chemistry, vol. 60, no. 18, pp. 4634-4640, 2012.
39. M. Zhang, S. W. Cui, P. C. K. Cheung, and Q. Wang, "Antitumor polysaccharides from mushrooms: a review on their isolation process, structural characteristics and antitumor activity, " Trends in Food Science and Technology, vol. 18, no. 1, pp. 4-19, 2007.
40. S. Wasser, "Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides, " Applied Microbiology and Biotechnology, vol. 60, no. 3, pp. 258-274, 2002.
41. F. M. Klis, P. De Groot, and K. Hellingwerf, "Molecular organization of the cell wall of Candida albicans, " Medical Mycology, vol. 39, no. 1, pp. 1-8, 2001.
42. M. McIntosh, B. A. Stone, and V. A. Stanisich, "Curdlan and other bacterial (1→3)-β-D-glucans, " Applied Microbiology and Biotechnology, vol. 68, no. 2, pp. 163-173, 2005.
43. F. Schmid, B. A. Stone, B. M. McDougall et al., "Structure of epiglucan, a highly side-chain/branched (1/3;1/6)-β-glucan from the micro fungus Epicoccum nigrum Ehrenb. ex Schlecht, " Carbohydrate Research, vol. 331, no. 2, pp. 163-171, 2001.
44. B. H. Falch, T. Espevik, L. Ryan, and B. T. Stokke, "The cytokine stimulating activity of (1→3)-β-D-glucans is dependent on the triple helix conformation, " Carbohydrate Research, vol. 329, no. 3, pp. 587-596, 2000.
45. K.-I. Ishibashi, N. N. Miura, Y. Adachi, N. Ohno, and T. Yadomae, "Relationship between solubility of grifolan, a Fungal 1, 3-β-D-glucan, and production of tumor necrosis factor by macrophages in vitro, " Bioscience, Biotechnology and Biochemistry, vol. 65, no. 9, pp. 1993-2000, 2001.
46. K. Kataoka, T. Muta, S. Yamazaki, and K. Takeshige, "Activation of macrophages by linear (1→3)-β-D-glucans. Implications for the recognition of fungi by innate immunity, " Journal of Biological Chemistry, vol. 277, no. 39, pp. 36825-36831, 2002.
47. M. A. Khan, M. Tania, R. Liu, and M. M. Rahman, "Hericium erinaceus: an edible mushroom with medicinal values, " Journal of Complementary and Integrative Medicine, vol. 10, no. 1, pp. 253-258, 2013.
48. M. Mayell, "Maitake extracts and their therapeutic potential-a review, " Alternative Medicine Review, vol. 6, no. 1, pp. 48-60, 2001.
49. V. Vetvicka and J.-C. Yvin, "Effects of marine β-1, 3 glucan on immune reactions, " International Immunopharmacology, vol. 4, no. 6, pp. 721-730, 2004.
50. P. Manzi and L. Pizzoferrato, "Beta-glucans in edible mushrooms, " Food Chemistry, vol. 68, no. 3, pp. 315-318, 2000.
51. A. S. Daba and O. U. Ezeronye, "Minireview. Anti-cancer effect of polysaccharides isolated from higher basidiomycetes mushrooms, " African Journal of Biotechnology, vol. 2, pp. 272-278, 2003.
52. X. Xu, H. Yan, J. Chen, and X. Zhang, "Bioactive proteins from mushrooms, " Biotechnology Advances, vol. 29, no. 6, pp. 667-674, 2011.
53. R. S. Singh, R. Bhari, and H. P. Kaur, "Mushroom lectins: current status and future perspectives, " Critical Reviews in Biotechnology, vol. 30, no. 2, pp. 99-126, 2010.
54. G. Q. Zhang, J. Sun, H. X. Wang, and T. B. Ng, "A novel lectin with antiproliferative activity from the medicinal mushroom Pholiota adiposa, " Acta Biochimica Polonica, vol. 56, no. 3, pp. 415-421, 2009.
55. C.-H. Lin, G.-T. Sheu, Y.-W. Lin et al., "A new immunomodulatory protein from Ganoderma microsporum inhibits epidermal growth factor mediated migration and invasion in A549 lung cancer cells, " Process Biochemistry, vol. 45, no. 9, pp. 1537-1542, 2010.
56. K. Hensley, E. J. Benaksas, R. Bolli et al., "New perspectives on vitamin E:-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine, " Free Radical Biology and Medicine, vol. 36, no. 1, pp. 1-15, 2004.
57. N. Balasundram, K. Sundram, and S. Samman, "Phenolic compounds in plants and agri-industrial by-products: antioxidant activity, occurrence, and potential uses, " Food Chemistry, vol. 99, no. 1, pp. 191-203, 2006.
58. B. N. Ames, M. K. Shigenaga, and T. M. Hagen, "Oxidants, antioxidants, and the degenerative diseases of aging, " Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 17, pp. 7915-7922, 1993.
59. P. V. Hung and N. N. Y. Nhi, "Nutritional composition and antioxidant capacity of several edible mushrooms grown in the Southern Vietnam, " International Food Research Journal, vol. 19, no. 2, pp. 611-615, 2012.
60. J. Lee, J.-H. Hong, J.-D. Kim et al., "The antioxidant properties of solid-culture extracts of basidiomycetous fungi, " Journal of General and Applied Microbiology, vol. 59, no. 4, pp. 279-285, 2013.
61. R. J. Nijveldt, E. vanNood, D. E. C. vanHoorn, P. G. Boelens, K. van Norren, and P. A. M. van Leeuwen, "Flavonoids: a review of probable mechanisms of action and potential applications, " The American Journal of Clinical Nutrition, vol. 74, no. 4, pp. 418-425, 2001.
62. I. Palacios, M. Lozano, C. Moro et al., "Antioxidant properties of phenolic compounds occurring in edible mushrooms, " Food Chemistry, vol. 128, no. 3, pp. 674-678, 2011.
63. F. Firenzuoli, L. Gori, and G. Lombardo, "The medicinal mushroom Agaricus blazei Murrill: review of literature and pharmaco-toxicological problems, " Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 3-15, 2008.
64. C. U. J. O. Lima, C. O. D. A. Cordova, O. D. T. Nóbrega, S. S. Funghetto, and M. G. D. O. Karnikowski, "Does the Agaricus blazeiMurillmushroomhave properties that affect the immune system? An integrative review, " Journal of Medicinal Food, vol. 14, no. 1-2, pp. 2-8, 2011.
65. L. S. Adams, S. Phung, X. Wu, L. Ki, and S. Chen, "White button mushroom (Agaricus bisporus) exhibits antiproliferative and proapoptotic properties and inhibits prostate tumor growth in athymic mice, " Nutrition and Cancer, vol. 60, no. 6, pp. 744-756, 2008.
66. H.-H. Chang, P.-J. Chien, M.-H. Tong, and F. Sheu, "Mushroom immunomodulatory proteins possess potential thermal/freezing resistance, acid/alkali tolerance and dehydration stability, " Food Chemistry, vol. 105, no. 2, pp. 597-605, 2007.
67. R. A. Hakime-Silva, J. C. R. Vellosa, N. M. Khalil, O. A. K. Khalil, I. L. Brunetti, and O. M. M. F. Oliveira, "Chemical, enzymatic and cellular antioxidant activity studies of Agaricus blazei Murrill, " Anais da Academia Brasileira de Ciencias, vol. 85, no. 3, pp. 1073-1081, 2013.
68. R. Kaneno, L. M. Fontanari, S. A. Santos, L. C. Di Stasi, E. Rodrigues Filho, and A. F. Eira, "Effects of extracts fromBrazilian sun-mushroom (Agaricus blazei) on the NK activity and lymphoproliferative responsiveness of Ehrlich tumor-bearing mice, " Food and Chemical Toxicology, vol. 42, no. 6, pp. 909-916, 2004.
69. R. D. Delmanto, P. L. A. de Lima, M. M. Sugui et al., "Antimutagenic effect of Agaricus blazei Murrill mushroom on the genotoxicity induced by cyclophosphamide, " Mutation Research, vol. 496, no. 1-2, pp. 15-21, 2001.
70. A. M. Al-Dbass, S. K. Al-Daihan, and R. S. Bhat, "Agaricus blazei Murill as an efficient hepatoprotective and antioxidant agent against CCl4-induced liver injury in rats, " Saudi Journal of Biological Sciences, vol. 19, no. 3, pp. 303-309, 2012.
71. A. E. S. S. Carvajal, E. A. Koehnlein, A. A. Soares et al., "Bioactives of fruiting bodies and submerged culture mycelia of Agaricus brasiliensis (A. blazei) and their antioxidant properties, " LWT: Food Science and Technology, vol. 46, no. 2, pp. 493-499, 2012.
72. T. Takaku, Y. Kimura, and H. Okuda, "Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action, " Journal of Nutrition, vol. 131, no. 5, pp. 1409-1413, 2001.
73. K. Wisitrassameewong, S. C. Karunarathna, N. Thongklang et al., "Agaricus subrufescens: a review, " Saudi Journal of Biological Sciences, vol. 19, no. 2, pp. 131-146, 2012.
74. P. S. Bisen, R. K. Baghel, B. S. Sanodiya, G. S. Thakur, and G. B. K. S. Prasad, "Lentinus edodes: a macrofungus with pharmacological activities, " Current Medicinal Chemistry, vol. 17, no. 22, pp. 2419-2430, 2010.
75. H. Chen, Y. Ju, J. Li, and M. Yu, "Antioxidant activities of polysaccharides from Lentinus edodes and their significance for disease prevention, " International Journal of Biological Macromolecules, vol. 50, no. 1, pp. 214-218, 2012.
76. S.-B. Han, C. W. Lee, J. S. Kang et al., "Acidic polysaccharide from Phellinus linteus inhibits melanoma cell metastasis by blocking cell adhesion and invasion, " International Immunopharmacology, vol. 6, no. 4, pp. 697-702, 2006.
77. C. S. G. Kitzberger, A. Smania Jr., R. C. Pedrosa, and S. R. S. Ferreira, "Antioxidant and antimicrobial activities of shiitake (Lentinula edodes) extracts obtained by organic solvents and supercritical fluids, " Journal of Food Engineering, vol. 80, no. 2, pp. 631-638, 2007.
78. J.-C. Wang, S.-H. Hu, Z.-C. Liang, and C.-J. Yeh, "Optimization for the production of water-soluble polysaccharide from Pleurotus citrinopileatus insubmerged culture and its antitumor effect, "AppliedMicrobiology and Biotechnology, vol. 67, no. 6, pp. 759-766, 2005.
79. H.-Y. Kim, J.-H. Kim, S.-B. Yang et al., "A polysaccharide extracted from rice bran fermented with Lentinus edodes enhances natural killer cell activity and exhibits anticancer effects, " Journal ofMedicinal Food, vol. 10, no. 1, pp. 25-31, 2007.
80. Y. Yamaguchi, E. Miyahara, and J. Hihara, "Efficacy and safety of orally administered Lentinula edodes mycelia extract for patients undergoing cancer chemotherapy: a pilot study, " American Journal of ChineseMedicine, vol. 39, no. 3, pp. 451-459, 2011.
81. N. Armassa, O. Poungchompu, S. Rayan, S. Leethong, N. Weerapreeyakul, and S. Machana, "Antioxidant activity and cytotoxicity in breast cancer cells line of mushrooms extracts; Lentinus polychrous Lev.compared to Ganoderma lucidum (Fr.) Karst, " Isan Journal of Pharmaceutical Sciences, vol. 5, pp. 243-250, 2009.
82. C. Thetsrimuang, S. Khammuang, and R. Sarnthima, "Antioxidant activity of crude polysaccharides from edible fresh and dry mushroom fruiting bodies of Lentinus sp. strain RJ-2, " International Journal of Pharmacology, vol. 7, no. 1, pp. 58-65, 2011.
83. C. Thetsrimuang, S. Khammuang, K. Chiablaem, C. Srisomsap, and R. Sarnthima, "Antioxidant properties and cytotoxicity of crude polysaccharides from Lentinus polychrous Lév, " Food Chemistry, vol. 128, no. 3, pp. 634-639, 2011.
84. N. Fangkrathok, B. Sripanidkulchai, K. Umehara, and H. Noguchi, "Bioactive ergostanoids and a newpolyhydroxyoctane fromLentinus polychrousmycelia and their inhibitory effects on E2-enhanced cell proliferation of T47D cells, " Natural Product Research, vol. 27, no. 18, pp. 1611-1619, 2013.
85. T. Jayakumar, M. Sakthivel, P. A. Thomas, and P. Geraldine, "Pleurotus ostreatus, an oyster mushroom, decreases the oxidative stress induced by carbon tetrachloride in rat kidneys, heart and brain, " Chemico-Biological Interactions, vol. 176, no. 2-3, pp. 108-120, 2008.
86. A. Jedinak and D. Sliva, "Pleurotus ostreatus inhibits proliferation of human breast and colon cancer cells through p53-dependent as well as p53-independent pathway, " International Journal of Oncology, vol. 33, no. 6, pp. 1307-1313, 2008.
87. I. Lavi, D. Friesem, S. Geresh, Y. Hadar, and B. Schwartz, "An aqueous polysaccharide extract from the edible mushroom Pleurotus ostreatus induces anti-proliferative and pro-apoptotic effects on HT-29 colon cancer cells, " Cancer Letters, vol. 244, no. 1, pp. 61-70, 2006.
88. K. K. Mishra, R. S. Pal, R. Arunkumar, C. Chandrashekara, S. K. Jain, and J. C. Bhatt, "Antioxidant properties of different edible mushroom species and increased bioconversion efficiency of Pleurotus eryngii using locally available casing materials, " Food Chemistry, vol. 138, no. 2-3, pp. 1557-1563, 2013.
89. K. Mori, C. Kobayashi, T. Tomita, S. Inatomi, and M. Ikeda, "Antiatherosclerotic effect of the edible mushrooms Pleurotus eryngii (Eringi), Grifola frondosa (Maitake), and Hypsizygus marmoreus (Bunashimeji) in apolipoprotein E-deficient mice, " Nutrition Research, vol. 28, no. 5, pp. 335-342, 2008.
90. L. K. Jagadish, R. Shenbhagaraman, V. Venkatakrishnan, and V. Kaviyarasan, "Studies on the phytochemical, antioxidant and antimicrobial properties of three indigenous Pleurotus species, " Journal ofMolecular Biology and Biotechnology, vol. 1, pp. 20-29, 2008.
91. A. Jedinak, S. Dudhgaonkar, Q.-L. Wu, J. Simon, and D. Sliva, "Anti-inflammatory activity of edible oystermushroomis mediated through the inhibition of NF-κB and AP-1 signaling, " Nutrition Journal, vol. 10, article 52, 2011.
92. G. Kanagasabapathy, S. N. A. Malek, U. R. Kuppusamy, and S. Vikineswary, "Chemical composition and antioxidant properties of extracts of fresh fruiting bodies of Pleurotus sajor-caju (Fr.) singer, " Journal of Agricultural and FoodChemistry, vol. 59, no. 6, pp. 2618-2626, 2011.
93. M. Makropoulou, N. Aligiannis, Z. Gonou-Zagou, H. Pratsinis, A.-L. Skaltsounis, and N. Fokialakis, "Antioxidant and cytotoxic activity of the wild edible mushroom Gomphus clavatus, " Journal of Medicinal Food, vol. 15, no. 2, pp. 216-221, 2012.
94. F. R. Smiderle, L. M. Olsen, E. R. Carbonero et al., "Antiinflammatory and analgesic properties in a rodent model of a (1→3), (1→6)-linked β-glucan isolated from Pleurotus pulmonarius, " European Journal of Pharmacology, vol. 597, no. 1-3, pp. 86-91, 2008.
95. K. K. Maity, S. Patra, B. Dey et al., "A heteropolysaccharide from aqueous extract of an ediblemushroom, Pleurotus ostreatus cultivar: structural and biological studies, " Carbohydrate Research, vol. 346, no. 2, pp. 366-372, 2011.
96. H. Tong, F. Xia, K. Feng et al., "Structural characterization and in vitro antitumor activity of a novel polysaccharide isolated from the fruiting bodies of Pleurotus ostreatus, " Bioresource Technology, vol. 100, no. 4, pp. 1682-1686, 2009.
97. P. Bobek, L. Ozdín, and S. Galbavý, "Dose-and time-dependent hypocholesterolemic effect of oyster mushroom (Pleurotus ostreatus) in rats, " Nutrition, vol. 14, no. 3, pp. 282-286, 1998.
98. P. H. K. Ngai and T. B. Ng, "A ribonuclease with antimicrobial, antimitogenic and antiproliferative activities from the edible mushroomPleurotus sajor-caju, " Peptides, vol. 25, no. 1, pp. 11-17, 2004.
99. S.-M. Wong, K.-K. Wong, L. C.-M. Chiu, and P. C.-K. Cheung, "Non-starch polysaccharides from different developmental stages of Pleurotus tuber-regium inhibited the growth of human acute promyelocytic leukemia HL-60 cells by cell-cycle arrest and/or apoptotic induction, " Carbohydrate Polymers, vol. 68, no. 2, pp. 206-217, 2007.
100. Y. R. Li, Q. H. Liu, H. X. Wang, and T. B. Ng, "A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus, " Biochimica et Biophysica Acta, vol. 1780, no. 1, pp. 51-57, 2008.
101. C.-W. Phan, W.-L. Wong, P. David, M. Naidu, and V. Sabaratnam, "Pleurotus giganteus (Berk.) Karunarathna and K. D. Hyde: nutritional value and in vitro neurite outgrowth activity in rat pheochromocytoma cells, " BMC Complementary and Alternative Medicine, vol. 12, article 102, 2012.
102. W.-L. Wong, M. A. Abdulla, K.-H. Chua, U. R. Kuppusamy, Y.-S. Tan, and V. Sabaratnam, "Hepatoprotective effects of Panus giganteus (Berk.) corner against thioacetamide-(TAA-) induced liver injury in rats, " Evidence-Based Complementary and AlternativeMedicine, vol. 2012, Article ID 170303, 10 pages, 2012.
103. G.-Q. Liu and K.-C. Zhang, "Mechanisms of the anticancer action of Ganoderma lucidum (Leyss. ex Fr.) Karst. : a new understanding, " Journal of Integrative Plant Biology, vol. 47, no. 2, pp. 129-135, 2005.
104. X. W. Zhou, K. Q. Su, and Y. M. Zhang, "Applied modern biotechnology for cultivation of Ganoderma and development of their products, " Applied Microbiology and Biotechnology, vol. 93, no. 3, pp. 941-963, 2012.
105. J. Mahajna, N. Dotan, B.-Z. Zaidman, R. D. Petrova, and S. P. Wasser, "Pharmacological values of medicinal mushrooms for prostate cancer therapy: the case of Ganoderma lucidum, " Nutrition and Cancer, vol. 61, no. 1, pp. 16-26, 2009.
106. X. W. Zhou, J. Lin, Q. Z. Li, Y. Z. Yin, X. F. Sun, and K. X. Tang, "Study progress on bioactive proteins from Ganoderma spp, " Natural Products Research Development, vol. 19, pp. 916-924, 2007.
107. S.-C. Hsu, C.-C. Ou, J.-W. Li et al., "Ganoderma tsugae extracts inhibit colorectal cancer cell growth via G2/M cell cycle arrest, " Journal of Ethnopharmacology, vol. 120, no. 3, pp. 394-401, 2008.
108. Z.-B. Lin and H.-N. Zhang, "Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms, " Acta Pharmacologica Sinica, vol. 25, no. 11, pp. 1387-1395, 2004.
109. R. R. M. Paterson, "Ganoderma-a therapeutic fungal biofactory, " Phytochemistry, vol. 67, no. 18, pp. 1985-2001, 2006.
110. T. G. Pillai, C. K. K. Nair, and K. K. Janardhanan, "Enhancement of repair of radiation induced DNA strand breaks in human cells by Ganoderma mushroom polysaccharides, " Food Chemistry, vol. 119, no. 3, pp. 1040-1043, 2010.
111. J. T. Xie, C. Z. Wang, S. Wicks et al., "Ganoderma lucidum extract inhibits proliferation of SW 480 human colorectal cancer cells, " Experimental Oncology, vol. 28, no. 1, pp. 25-29, 2006.
112. N.-H. Chen and J.-J. Zhong, "p53 is important for the antiinvasion of ganoderic acid T in human carcinoma cells, " Phytomedicine, vol. 18, no. 8-9, pp. 719-725, 2011.
113. L. Ye, J. Zhang, S. Zhou, S. Wang, D. Wu, and Y. Pan, "Preparation of a novel sulfated glycopeptide complex and inhibiting L1210 cell lines property in vitro, " Carbohydrate Polymers, vol. 77, no. 2, pp. 276-279, 2009.
114. L. K. Lai, N. Z. Abidin, N. Abdullah, and V. Sabaratnam, "Antihuman papillomavirus (HPV) 16 E6 activity of Ling Zhi or Reishi medicinal mushroom, Ganoderma lucidum (W. Curt. : Fr.) P. Karst. (Aphyllophoromycetideae) extracts, " International Journal of Medicinal Mushrooms, vol. 12, no. 3, pp. 279-286, 2010.
115. C.-J. Weng and G.-C. Yen, "The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion andmetastasis, " Clinical and Experimental Metastasis, vol. 27, no. 5, pp. 361-369, 2010.
116. O. Olaku and J. D. White, "Herbal therapy use by cancer patients: a literature review on case reports, " European Journal of Cancer, vol. 47, no. 4, pp. 508-514, 2011.
117. B. S. Sanodiya, G. S. Thakur, R. K. Baghel, G. B. K. S. Prasad, and P. S. Bisen, "Ganoderma lucidum: a potent pharmacological macrofungus, " Current Pharmaceutical Biotechnology, vol. 10, no. 8, pp. 717-742, 2009.
118. M.-S. Shiao, "Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions, " Chemical Record, vol. 3, no. 3, pp. 172-180, 2003.
119. D. Sliva, "Ganoderma lucidum (Reishi) in cancer treatment, " Integrative CancerTherapies, vol. 2, no. 4, pp. 358-364, 2003.
120. X. Zhou, J. Lin, Y. Yin, J. Zhao, X. Sun, and K. Tang, "Ganodermataceae: natural products and their related pharmacological functions, " The American Journal of Chinese Medicine, vol. 35, no. 4, pp. 559-574, 2007.
121. G. Stanley, K. Harvey, V. Slivova, J. Jiang, and D. Sliva, "Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-β1 from prostate cancer cells, " Biochemical and Biophysical Research Communications, vol. 330, no. 1, pp. 46-52, 2005.
122. B. Boh, "Ganoderma lucidum: a potential for biotechnological production of anti-cancer and immunomodulatory drugs, " Recent Patents on Anti-Cancer Drug Discovery, vol. 8, no. 3, pp. 255-287, 2013.
123. M. E. Valverde, T. Hernandez-Perez, and O. Paredes-Lopez, "Huitlacoche-a 21st century culinary delight originated in the Aztec times, " in Hispanic Foods: Chemistry and Bioactive Compounds, M. H. Tunick and E. Gonzlez de Meji, Eds., vol. 1109, American Chemical Society, Washington, DC, USA, 2012.
124. M. E. Valverde and O. Paredes Lopez, "Production and evaluation of some food properties of huitlacoche (Ustilago maydis), " Food Biotechnology, vol. 7, no. 3, pp. 207-220, 1993.
125. P. E. Vanegas, M. E. Valverde, O. Paredes-Lopez, and J. K. Pataky, "Production of the edible fungus huitlacoche (Ustilago maydis): effect of maize genotype on chemical composition, " Journal of Fermentation and Bioengineering, vol. 80, no. 1, pp. 104-106, 1995.
126. M. Valdez-Morales, K. Barry, G. C. Fahey Jr. et al., "Effect of maize genotype, developmental stage, and cooking process on the nutraceutical potential of huitlacoche (Ustilago maydis), " Food Chemistry, vol. 119, no. 2, pp. 689-697, 2010.
127. K. K. W. Chu, S. S. S. Ho, and A. H. L. Chow, "Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values, " Journal of Clinical Pharmacology, vol. 42, no. 9, pp. 976-984, 2002.
128. L. J. Standish, C. A. Wenner, E. S. Sweet et al., "Trametes versicolor mushroomimmune therapy in breast cancer, " Journal of the Society for Integrative Oncology, vol. 6, no. 3, pp. 122-128, 2008.
129. Y. Masuda, M. Inoue, A. Miyata, S. Mizuno, and H. Nanba, "Maitake β-glucan enhances therapeutic effect and reduces myelosupression and nephrotoxicity of cisplatin in mice, " International Immunopharmacology, vol. 9, no. 5, pp. 620-626, 2009.
130. B. J. Shi, X. H. Nie, L. Z. Chen, Y. L. Liu, and W. Y. Tao, "Anticancer activities of a chemically sulfated polysaccharide obtained from Grifola frondosa and its combination with 5-fluorouracil against human gastric carcinoma cells, " Carbohydrate Polymers, vol. 68, no. 4, pp. 687-692, 2007.
131. S. K. Das, M. Masuda, A. Sakurai, and M. Sakakibara, "Medicinal uses of themushroomCordyceps militaris: current state and prospects, " Fitoterapia, vol. 81, no. 8, pp. 961-968, 2010.
132. T. B. Ng and H. X. Wang, "Pharmacological actions of Cordyceps, a prized folk medicine, " Journal of Pharmacy and Pharmacology, vol. 57, no. 12, pp. 1509-1519, 2005.
133. Y. K. Rao, S.-H. Fang, W.-S. Wu, and Y.-M. Tzeng, "Constituents isolated from Cordyceps militaris suppress enhanced inflammatory mediator's production and human cancer cell proliferation, " Journal of Ethnopharmacology, vol. 131, no. 2, pp. 363-367, 2010.
134. X. Zhou, Z. Gong, Y. Su, J. Lin, and K. Tang, "Cordyceps fungi: natural products, pharmacological functions and developmental products, " Journal of Pharmacy and Pharmacology, vol. 61, no. 3, pp. 279-291, 2009.
135. Y.-F. Chen, W.-L. Lu, M.-D. Wu, and G.-F. Yuan, "Analysis of Taiwan patents for the medicinal mushroom "niu-Chang-Chih", " Recent Patents on Food, Nutrition and Agriculture, vol. 5, no. 1, pp. 62-69, 2013.
136. N. Inoue, M. Inafuku, B. Shirouchi, K. Nagao, and T. Yanagita, "Effect of Mukitake mushroom (Panellus serotinus) on the pathogenesis of lipid abnormalities in obese, diabetic ob/ob mice, " Lipids in Health and Disease, vol. 12, no. 1, article 18, 2013.
137. J. Yu, R. Sun, Z. Zhao, and Y. Wang, "Auricularia polytricha polysaccharides induce cell cycle arrest and apoptosis in human lung cancer A549 cells, " International Journal of Biological Macromolecules, vol. 68, pp. 67-71, 2014.
138. M. A. Reza, M. A. Hossain, S. J. Lee et al., "Dichlormethane extract of the jelly ear mushroom Auricularia auricula-judae (higher Basidiomycetes) inhibits tumor cell growth in vitro, " International Journal ofMedicinalMushrooms, vol. 16, no. 1, pp. 37-47, 2014.
139. M.-Y. Yeh, W.-C. Ko, and L.-Y. Lin, "Hypolipidemic and antioxidant activity of enoki mushrooms (Flammulina velutipes), " BioMed Research International, vol. 2014, Article ID 352385, 6 pages, 2014.